Background {#Sec1}
==========

Sclerosing epithelioid fibrosarcoma (SEF) is a rare malignant mesenchymal tumor of soft tissues composed of cords, nests or sheets of relatively monotonous epithelioid cells within a collagenous background. It has recently been characterized by recurrent FUS-CREB3L1, FUS-CREB3L2 or EWS1-CREB3L1 translocations and immunohistochemical MUC4 expression \[[@CR1]--[@CR3]\]. The tumor occurs over a wide age spectrum at initial presentation without sex predilection. Most reported cases are in the soft tissue of extremities and limb girdles \[[@CR4]--[@CR7]\]. Primary SEF in visceral organs is exceedingly rare, with only a few cases reported.

Here, we present two cases of SEF with primary renal origin bearing a EWS1-CREB3L1 gene fusion, as supported by MUC4 immunostaining and fluorescence in situ hybridization (FISH). To our knowledge, these are the sixth and seventh genetically confirmed cases of SEF reported in the kidney following very recently described primary renal SEF(s) by Arbajian et al., Argani et al. and Ohlmann, et al. \[[@CR1], [@CR8], [@CR9]\]. Some of their morphologic features are unique and deserve to be noted for full characterization of this entity in a new environment.

Case presentation {#Sec2}
=================

Two cases of SEF that were found to harbor EWSR1-CREB3L1 fusion were encountered in the diagnostic practice of the authors. The clinical records were retrieved for analysis, and all available pathologic materials were reviewed.

Immunohistochemistry {#Sec3}
--------------------

For immunohistochemical labeling, a polymer detection system (Leica, DS9800) and the BOND-MAX automated immunostainer was used. The standard antibodies consumed, vendors, and dilutions were summarized in Table [1](#Tab1){ref-type="table"}.Table 1Features of the antibodies used for the immunohistochemical stainsAntigenClone, dilution, sourcePan-CytokeratinAE1/AE3, 1:200, Leica, Newcastle/UKEpithelial Membrane AntigenE29, 1:300, Biocare, Concord/CAPAX8PAX8, 1:100, Biocare, Concord/CAWT16 F-H2, 1:40, DBS, Pleasenton/CAEREP1, 1:100, Genemed, San Francisco/CAPRSP2, 1:1000, Thermo, Fremont/CACD34QBEND/10, 1:100, DBS, Pleasenton/CASMA1A4, 1:1000, NeoMarkers, Fremont/CADesminD33, 1:50, Biocare, Concord/CAS100 proteinZ0311, 1:6000, DAKO, Glostrup/DenmarkGFAPGA-5, 1:50, Thermo, Fremont/CABcl2Bcl-2-100, 1:80, Invitrogen, Paisley/UKCD99HO36-1.1, 1:100, Thermo, Fremont/CAMUC41G8, 1:50, Invitrogen, Paisley/UKHMB45HMB45, 1:25, DBS, Pleasenton/CAMelan-AA103, 1:100, Thermo, Fremont/CAINI125, 1:50, Zeta, Arcadia/CA

Fluorescence In Situ Hybridization (FISH) {#Sec4}
-----------------------------------------

FISH analysis was performed on representative 4--5 μm thick unstained formalin-fixed, paraffin-embedded tissue sections of the tumor samples of each case. For characterization of the possible underlying gene rearrangement or fusion gene events, the following FISH probe sets were utilized on both cases: Vysis LSI EWSR1 (22q12) and Vysis LSI FUS (16p11) Dual Color Break Apart Probes (Abbott Molecular, Inc., Des Plaines, IL) and *EWSR1* and *CREB3L1* spanning probe sets using cocktails of BAC clones (RP11-945 M21 and RP11-1126O13, and RP11-1014A16, RP11-1106 J11 and RP11-481I24 respectively) selected on the basis of their location per the UCSC Human Genome Browser \[<http://genome.ucsc.edu/cgi-bin/hgGateway>\] and obtained from BAC/PAC Resources Center (Children's Hospital Oakland Research Institute, Oakland, CA, USA).

Hybridization studies using the Vysis LSI Dual Color Break Apart Probes for the assessment of rearrangement of the *FUS* and *EWSR1* loci were performed following the manufacturer's instructions (Abbott Molecular, Inc., Des Plaines, IL). With respect to the custom spanning probes, each BAC clone was directly labeled by nick translation with either Spectrum Green- or Spectrum Orange-dUTP per the manufacturer's protocol (Abbott Molecular, Inc., Des Plaines, IL). An amount of 3 ug of DNA for each probe or 1.5 ug for each of two probes were combined. All nick translation reagents were then multiplied by the total ug of DNA used in the cocktail. Amounts of 200 ng of each probe were hybridized to the target DNA and blocked with approximately 15 fold excess of a combination of Human Cot-I DNA (Invitrogen, Carlsbad, CA) and human placental DNA.

Prior to hybridization, the slides were pretreated at room temperature in 0.2 N HCl for 20 min, washed in water for 3 min, incubated at 80 °C for 25 min in VP 2000 Pretreatment Reagent (Abbott Molecular, Inc., Des Plaines, IL) and then washed again in water for 3 min. Subsequently, the slides were incubated for 15 min at 37 °C in protease solution \[25 mg of protease in 50 ml of protease solution (Abbott Molecular, Inc., Des Plaines, IL), washed in 1 × PBS at room temperature for 5 min and then dehydrated in gradient ethanol (75, 85, and 100 %) at room temperature for 1 min each and air-dried. After the cells and probes were co-denatured at 80 °C for 10 min and incubated overnight at 37 °C using the HYBrite™ system (Abbott Molecular, Inc., Des Plaines, IL), post-hybridization washing was performed in 2 × SSC/0.1 % NP-40 at 72 °C for 2 min, followed by 2 × SSC/0.1 % NP-40 at room temperature for 1 min. The slides were then counterstained with DAPI II (Abbott Molecular, Inc., Des Plaines, IL). To confirm correct mapping, optimal signal strength, and lack of cross-hybridization, each probe set was also hybridized to metaphase cell preparations of karyotypically normal peripheral blood lymphocytes before proceeding with analysis of the patient samples.

The cutoff level for scoring a specimen as positive for a rearrangement of the *FUS* or *EWSR1* locus or as positive for an *EWSR1/CREB3L1* fusion was \>15 % of the cells evaluated. Images were prepared using the Cytovision Image Analysis System (Applied Imaging, Santa Clara, CA). For each probe set, 100--200 interphase nuclei with strong and well-delineated signals were examined.

Case 1 {#Sec5}
------

The patient was a 16-year-old girl who presented at the urology clinics with pain on the left side of the abdomen radiating to the back. Her past medical history was insignificant. Computerized axial tomography scans of the chest, abdomen, and pelvis revealed a 70 × 70 × 60 mm left renal mass (Fig. [1](#Fig1){ref-type="fig"}), bilateral pulmonary nodules (the largest being 16 mm in diameter), and widespread bone metastases in vertebrae, sacrum and left femoral head. A biopsy from the tumor in the kidney through laparotomy was performed followed by left radical nephrectomy after the diagnosis of malignancy.Fig. 1Case \#1. Computerized tomography scan showing a large tumor in the left kidney

Tumor occupied the entire upper half of the kidney, extended into the renal sinus, was a solid white unencapsulated lesion with sharp borders, measuring 7.5 × 7 × 7 cm in size (Fig. [2](#Fig2){ref-type="fig"}). Microscopical sections showed diffuse infiltration of the neoplastic tissue in kidney parenchyma separating normal renal elements from each other. The neoplastic cells were small, monotonous and epithelioid with clear to pale eosinophilic cytoplasm, and were arranged in single files, cords, nests or irregular aggregates in collagenous matrix (Fig. [3](#Fig3){ref-type="fig"}). Nuclei were generally round to oval, with indistinct nucleoli. Hypercellular areas alternated randomly with hypocellular densely hyalinized or at times myxoid stroma. Additionally, a peculiar lobular organization was noted in many regions where a renal tubule in the center was surrounded by concentric inner hypo and outer hypercellular zones of neoplastic cells (Fig. [4a](#Fig4){ref-type="fig"} and [b](#Fig4){ref-type="fig"}). These lobules were separated from each other by myofibroblasts. Tubules entrapped in the tumor were lined by single layered Pax-8 positive cuboidal cells without atypia, some showed shallow papillary hyperplasia and rare mitosis. Mitotic rate was 1/10 hpf in the neoplasm and there were occasional areas of necrosis in the tumor. Hypercellular areas occasionally contained vague nodules of collagen mimicking those seen in hyalinizing spindle cell tumor with giant rosettes (HSCTGR). The surrounding kidney showed no specific pathologic changes. By immunohistochemistry, neoplastic cells were immunoreactive diffusely and strongly for vimentin, bcl-2 and CD99; EMA labelled them in a weak and patchy fashion (Fig. [5](#Fig5){ref-type="fig"}). They were negative for pan-cytokeratin, Pax-8, WT-1, CD34, S-100, GFAP, Melan-A, HMB-45, desmin, and estrogen and progesterone receptors. Smooth muscle actin (SMA) stained myofibroblastic cells in-between the neoplastic lobules (Fig. [6](#Fig6){ref-type="fig"}). INI-1 was preserved. Then, an immunohistochemical stain for MUC4 was performed which showed strong positivity throughout the tumor (Fig. [6](#Fig6){ref-type="fig"}). Finally, FISH analysis with the EWSR1 Break Apart probe revealed loss of one copy of the Spectrum Green labeled probe flanking the 3' (telomeric) side of the *EWSR1* gene as well as the presence of a single fused *EWSR1/CREB3L1* signal (represented by a juxtaposed orange signal and green signal) consistent with the presence of an unbalanced der(22)t(11;22)(p11;q12) (Fig. [7](#Fig7){ref-type="fig"}), confirming the diagnosis of sclerosing epithelioid fibrosarcoma. FISH study was negative for a rearrangement of the *FUS* gene locus.Fig. 2Case \#1. Solid white tumor filling out the upper half of the kidneyFig. 3Case \#1. Alternating hypercellular and a hypocellular areas of neoplastic cells with monomorphic ovoid nuclei and indistinct pale to clear cytoplasm (H&E x 200; inset: H&E x 400)Fig. 4Case \#1. **a** Lobular/micronodular pattern (H&E x 40). **b** Concentric hypocellular inner, hypercellular outer zone around entrapped renal tubules (H&E x 100)Fig. 5Case \#1. Strong bcl-2 and weak EMA expression by neoplastic cells (*Left*: Immunohistochemistry, anti-bcl-2 Ab x 200; *Right*: Immunohistochemistry, anti-EMA Ab x 200)Fig. 6Case \#1. SMA stains myofibroblasts between neoplastic lobules and MUC4 stains neoplastic cells (*Left*: Immunohistochemistry, anti-SMA Ab x 100; *Right*: Immunohistochemistry, anti-MUC4 Ab x 400)Fig. 7Case \#1. An *EWSR1* Break Apart probe set and a custom probe set spanning the *EWSR1* (Spectrum Orange) and the *CREB3L1* (Spectrum Green) loci demonstrating loss of the Spectrum Green labeled probe signal that flanks the 3' (telomeric) side of the *EWSR1* locus (short arrows, left panel) and a single fusion signal (long arrows, right panel)

Patient was given chemotherapy with multiple agents. She is alive with disease after 30 month follow-up.

Case 2 {#Sec6}
------

The patient was a 57-year-old woman who was investigated for cholelithiasis due to dyspeptic complaints. During abdominal ultrasonography, she was found to have a left renal mass incidentally. The CT scan showed that the tumor was located at the upper pole of the kidney and was measured 6 cm in the largest diameter. Her past medical history was unremarkable except for hypertension, congestive heart failure and arrhythmia. Serum and urine tests were within the normal limits. The patient subsequently underwent open left partial nephrectomy.

On gross examination, the specimen had an unencapsulated, solid - white firm tumor with irregular borders, measuring 7.5 × 5.5 × 4 cm (Fig. [8](#Fig8){ref-type="fig"}). Histologic examination revealed that tumor contained abundant entrapped native renal tubules throughout as in the first case, mimicking a biphasic neoplasm (Fig. [9](#Fig9){ref-type="fig"}). These tubules were hyperplastic and proliferating, were of various size and shapes, some being cystic or leaf-like, and lined by single layered cuboidal or occasionally flattened cells, all expressing nuclear Pax-8. Intraluminal papillary projections were common, but without cytologic atypia. Neoplastic component had a variable cellularity (Fig. [10](#Fig10){ref-type="fig"}). Hypocellular regions contained abundant hyalinized collagen and some showed myxoid change. Hypercellular areas were divided into anastomosing compartments by sclerotic collagen bands. Neoplastic cells were polygonal epithelioid or plump spindle type forming short fascicles (Fig. [11](#Fig11){ref-type="fig"}). Cytoplasm was clear or eosinophilic. Cellular pleomorphism was prominent with scattered bizarre and hyperchromatic nuclei, intranuclear inclusions were evident in some. Tumor abutted lining urothelium of renal pelvis without ulceration and formed large hypocellular sheets of short spindle cells in myxoid matrix encircling pelvic wall. There were rare foci of necrosis. Mitotic rate ranged 5--10/10 hpf. Immunohistochemical profile of tumor was similar to the first case including strong and diffuse MUC4, vimentin and bcl-2, weak EMA expression (Fig. [12](#Fig12){ref-type="fig"}) except negative immunoreactivity for CD99. SMA showed frequently scattered myofibroblasts between the tumor cells. FISH demonstrated an unbalanced der(22)t(11;22)(p11;q12), as in the case \#1 (Fig. [13](#Fig13){ref-type="fig"}). A *FUS* gene rearrangement was not identified.Fig. 8Case \#2. Gross photograph of the kidney in patient no. 2 shows a well-defined solid mass that extends to surgical margin of the partial nephrectomy specimenFig. 9Case \#2. Proliferating native renal tubules inside the tumor giving an appearance of a biphasic lesion (H&E x 100). Inset shows that hyperplastic tubules maintain nuclear pax-8 (H&E x 40)Fig. 10Case \#2. Hyper and hypocellular regions (*Left*: H&E x 200; *Right*: H&E x 200)Fig. 11Case \#2. Spindle cells forming short fascicles vaguely (H-E x 200). Inset highlights marked pleomorphism among the neoplastic cells (H-E x 400)Fig. 12Case \#2. SMA stains interspersed myofibroblasts and MUC4 labels neoplastic cells (*Left*: Immunohistochemistry, anti-SMA Ab x 200; *Right*: Immunohistochemistry, anti-MUC4 Ab x 200)Fig. 13Case \#2. FISH patterns similar to Case 1. *EWSR1* break apart with loss of one copy of the Spectrum Green labeled probe flanking the 3' (telomeric) side (left panel) and *EWSR1/CREB3L1* fusion seen by a juxtaposed orange signal and green signal (right panel)

The lesion occupied both renal cortex and medulla, and invaded into peripelvic and perirenal fat tissue. As one of the surgical margins was in continuation with the tumor, the patient underwent left radical nephrectomy which showed 1 cm residual mass. No adjuvant treatment was given. Patient is alive without local or distant recurrence 10 months after surgery.

Discussion {#Sec7}
==========

Sclerosing epithelioid fibrosarcoma (SEF) was first described by Meis-Kindblom et al. in 1995 \[[@CR6]\]. The most SEFs are deep seated lesions with a wide age range, but typically occurring in middle aged adults \[[@CR4], [@CR6]\]. The most frequent sites of involvement are deep soft tissues of lower extremities or limb girdle followed by trunk, upper extremities, and head and neck region, although primary SEF of unexpected locations such as bone, retroperitoneum, and pelvis were also described as case reports or small series \[[@CR10]--[@CR13]\]. Primary SEF in visceral organs is exceedingly rare, with only a single case reports in the liver \[[@CR12]\], the lower gastrointestinal tract \[[@CR11]\], the ovary \[[@CR14]\], and the pancreas \[[@CR10]\]. Occurrence of primary renal SEF was proven by Argani et al. who have recently reported 2 well-documented cases with rearrangement involving EWSR1 and CREB3L1 genes \[[@CR8]\] (Table [2](#Tab2){ref-type="table"}). There are also 3 additional cases in the literature described as primary renal SEFs which were shown to express MUC4 \[[@CR1], [@CR9]\]. Two of these had rearranged EWSR1 with undocumented fusion gene partner.Table 2Summary of reported cases of primary renal SEFAuthorsAge (years)GenderLargest Diameter /LateralityClinical presentationFISH FindingsTherapyMetastasesOutcome (mo)Arbajian, et al. \[[@CR1]\]41Female9 cm/NSNSEWSR1 Del 3′NSBone and lungDOD (22)Argani, et al. \[[@CR8]\]17Male25 cm/LLeft flank, back and abdominal pain, weight loss, dysuria, and decreased appetiteEWSR1-CREB3L1 fusionSurgery + RTRib, vertebrae, epidural spinal cord and liverDOC (1)Argani, et al. \[[@CR8]\]61Female5 cm/LRib painEWSR1-CERB3L1 fusionSurgeryRibs, bone, lung and lymph nodesAWD (6)Ohlmann, et al. \[[@CR9]\]24Female22 cm/RNSNo resultsSurgery + RCTLungs and vertebraeDOD (82)Ohlmann, et al. \[[@CR9]\]43Male4.2 cm/RIncidentalEWSR1 splitSurgeryNoneANED (8)Ertoy Baydar, et al. (present case)16Female7.5 cm/LAbdominal pain radiating to back on the leftEWSR1-CREB3L1 fusionSurgery + CTLungs, vertebrae, sacrum and left femoral headAWD (30)Ertoy Baydar, et al. (present case)57Female7.5 cm/LIncidentalEWSR1-CREB3L1 fusionSurgeryNoneANED (10)*NS* Not specified, *L* Left kidney, *R* Right kidney, *RT* Radiotherapy, *CT* chemotherapy, *RCT* Radiochemotherapy, *DOD* Died of disease, *DOC* Died of complications related to disease treatment, *AWD* Alive with disease, *ANED* Alive with no evidence of disease

SEF is a difficult diagnosis in visceral organs because of its rarity and its epithelioid appearance, closely mimicking carcinomas. It is characterized by a proliferation of epithelioid cells arranged in nests and cords in a densely hyalinized stroma (Table [3](#Tab3){ref-type="table"}). Neoplastic cells are positive for vimentin, bcl-2, MUC4, weakly and focally for epithelial membrane antigen (EMA), and are negative for broad spectrum cytokeratins, smooth muscle actin, desmin, CD34, S-100 protein, HMB45 and melan-A \[[@CR2], [@CR4], [@CR15]\]. MUC4 itself has been recently reported as highly specific for the diagnosis of SEF \[[@CR2]\]. Strong CD99 expression is seen in some cases. Most common genetic alteration described in pure SEFs is EWSR1-CREB3L1 fusion \[[@CR1]\]. Basic histomorphological differentials of SEF will be a variety of tumors with epithelioid and sclerotic features, mainly primary or metastatic carcinoma. Epithelioid angiomyolipoma, metanephric stromal tumor and synovial sarcoma are the other considerations in the differential diagnosis, as well as sclerosing clear cell sarcoma of the kidney (CCSK) being the most challenging. A battery of immunohistochemical stains will help for further characterization in most circumstances, however SEF and sclerosing type CCSK reveal both similar morphology and immunohistochemical findings Argani et al. suggest that some cases reported as sclerosing clear cell sarcoma of the kidney (CCSK) in the literature might in fact represent SEF \[[@CR8]\].Table 3Morphology of SEFTypical featuresMacroscopyLarge, homogeneously white or white--tan, lobulated, and hard tumorsCell size and shapeSmall to medium-sized plump to epithelioid cellsCytoplasmScant clear or eosinophilic cytoplasmNucleiOval to slightly elongate angulated nuclei with finely speckled chromatinCellularityVariable within the neoplasmAtypiaMildMatrixDensely sclerotic, areas of metaplastic bone in somePattern of cellular arrangementSmall clusters, nests and anastomosing cordsHybrid morphologyAreas of LGFMS or nodules of collagen reminiscent of HSCTGR in someImmunohistochemistryMUC4 ++, EMA +/−, CD99 +/−, bcl2 +/−, pan-keratin -, S100/HMB45/MelanA -FISHEWSR1 (or rarely FUS) rearrangementsPreviously unrecognized features in renal SEFCurrent case 1A lobular or micronodular architecture due to neoplastic cells surrounding entrapped renal tubules in a concentric fashionZonation in the neoplastic lobules around tubules with inner hypocellular and outer hypercellular appearanceCurrent case 2Exuberant epithelial hyperplasia and small gland budding in the entrapped native renal tubules, mimicking MESTHigh grade cytologic atypia*LGFMS* Low grade of fibromyxoid sarcoma, *HSCTGR* Hyalinizing spindle cell tumor with giant rosettes, *MEST* Mixed epithelial and stromal tumor of kidney

SEF and low-grade fibromyxoid sarcoma (LGFMS) are thought to be related members in the *fibrosing fibrosarcoma family* \[[@CR4]\]. Classic variants of LGFMS with or without giant rosettes constitute one end of the spectrum, characterized by a protracted clinical course and a low metastatic rate, whereas SEF or cellular variants of LGFMS constitute the other end which appears to be more aggressive. LGFMS may have SEF-like areas, and vice versa occurs in SEF lesions. Both tumors are labelled by immunohistochemical MUC4 staining, 99--100 % in LGFMS and 78 % in SEF, respectively \[[@CR2], [@CR16]\]. Furthermore, a genetic link between sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcoma has been suggested \[[@CR17]\]. Although majority (\>90 %) of LGFMS and hybrid LGFMS/SEF harbor t(7;16)(q33;p11) chromosome translocation resulting in FUS-CREB3L2 gene fusion, rare LGFMS carrying EWSR1-CREB3L1 gene fusion with t(11;22)(p11;q12) chromosome translocation was also found \[[@CR18]\]. There have been 5 cases of primary LGFMS described in kidney or renal pelvis so far, one in a 6 year old child, others in adults \[[@CR19]--[@CR23]\].

We report 2 distinctive, clinically malignant, renal SEF bearing EWSR1-CREB3L1 fusions through unbalanced translocation with unique histomorphologic features. The common finding in both was the diffuse infiltration of the tumor among renal tubules and glomeruli filling out the space in-between them. Numerous tubules and also glomeruli were seen entrapped throughout the tumors. In case \#1, neoplastic cells surrounded these tubules in a concentric onion-skin like pattern giving a lobular or micronodular architecture to the lesion in many areas. Additionally, the neoplastic sleeves around tubules revealed a zonation pattern with inner hypocellular and outer hypercellular appearance. This was a wide-spread occurrence involving also the deeper parts of the tumor, so differed from what is seen in CCSK or metanephric stromal tumor where neoplasm encircles native tubules at the tumor infiltration borders in a limited extent. No angiodysplasia or juxtaglomerular hyperplasia was found in our case.

The second case presented in this study varied from the first one in that the entrapped renal tubules exhibited prominent papillary hyperplasia and small gland budding which gave a biphasic appearance to the lesion. They were lined by cuboidal or flattened single layered epithelium devoid of atypia, some were cystic, and some looked fibroadenomatous and leaf-like due to compression by the interstitial neoplastic cells. It is quite likely that we would have diagnosed this lesion as malignant mixed epithelial and stromal tumor of kidney (MEST) only a few years ago when typical genetic alterations or MUC4 staining characteristic of this tumor type were unknown yet. In fact, we suspect that other examples of renal SEF may have been reported in the literature with an assignment as malignant MEST. Suzuki et al. \[[@CR24]\] reported a malignant MEST in a male with a prostatic adenocarcinoma under anti-androgen treatment, that was composed of atypical small round cells with a high nuclear cytoplasmic ratio without necrosis and pleomorphism, and also focal spindle cells without cytologic atypia in a gradual transition to small round cells. Immunohistochemically, tumor was bcl-2 and CD99+, SMA and S-100 -. *SYT-SSX1* and *SYT-SSX2* chimeric transcript were not identified. We suspect that at least this published case may represent the entity reported herein.

Another feature of the second case of this study that varied from the first one and from 5 cases reported previously was the presence of high grade cytologic atypia with noteworthy pleomorphism and scattered bizarre tumor cells. Most SEFs are cytologically uniform tumors with scanty mitoses; however, it is stated that foci of pleomorphism -particularly in hybrid SEF and LGFMS cases- and high mitotic activity can rarely be encountered \[[@CR4], [@CR7], [@CR17]\].

SEF is frequently characterized by aggressive clinical behavior \[[@CR4], [@CR6]\]. One or more local recurrences occur in approximately 50 % of cases, with metastatic spread being reported in more than 40 % of cases, most often affecting the pleura, lungs, bone and central nervous system. All of the cases reported previously except one and our first case were already metastatic at the time of presentation. As accurate recognition of SEF is important for appropriate patient management, we believe more cases need to be documented so that its full histomorphologic spectrum is uncovered.

Conclusions {#Sec8}
===========

Sclerosing epithelioid fibrosarcoma (SEF) is a rare soft tissue tumor that can occur in the kidney as a primary malignancy. Its misdiagnosis with other entities which are better known to develop in the kidney is a strong possibility as it has been only recently described and is unfamiliar to the pathologists. SEF is a neoplasm with variant morphological features that may overlap with many lesions confusingly. Immunohistochemistry and molecular studies that disclose the characteristic genetic alterations are crucial for accurate recognition.

Consent {#Sec9}
=======

Written informed consent was obtained from the parent (case \#1) and the patient (case \#2) for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
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